Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.37% |
| 2 | Healthcare | 7.45% |
| 3 | Consumer Discretionary | 5.14% |
| 4 | Industrials | 5.1% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RETA
2901
PUT
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $3.61M | ﹤0.01% |
35,400
+8,900
| +34% | +$842K |
|
2902
First Financial Corp
THFF
$956M
| $3.61M | ﹤0.01% |
111,089
-60,291
| -35% | -$2.06M |
|
2903
PUT
Norfolk Southern
NSC
$74.9B
| $3.61M | ﹤0.01% |
15,900
-30,000
| -65% | -$6.37M |
|
2904
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.9B
| $3.6M | ﹤0.01% |
41,650
-136,245
| -77% | -$11.6M |
|
2905
Beyond Air
XAIR
$3.89M
| $3.6M | ﹤0.01% |
2,112
+1,561
| +283% | +$3.57M |
|
2906
Vanguard FTSE Emerging Markets ETF
VWO
$120B
| $3.59M | ﹤0.01% |
+88,263
| New | +$3.56M |
|
|
UTAA
2907
DELISTED
UTA Acquisition Corporation Class A Ordinary Shares
UTAA
| $3.59M | ﹤0.01% |
340,000
| – | – |
|
2908
Amalgamated Financial
AMAL
$1.45B
| $3.59M | ﹤0.01% |
+222,839
| New | +$3.58M |
|
2909
Oil-Dri
ODC
$1.41B
| $3.59M | ﹤0.01% |
121,560
-60,344
| -33% | -$1.34M |
|
2910
Ternium
TX
$9.57B
| $3.57M | ﹤0.01% |
89,991
-188,275
| -68% | -$7.59M |
|
2911
CALL
Regions Financial
RF
$26.3B
| $3.56M | ﹤0.01% |
200,000
-130,100
| -39% | -$2.3M |
|
2912
El Pollo Loco
LOCO
$496M
| $3.56M | ﹤0.01% |
406,277
+46,100
| +13% | +$432K |
|
2913
Rocket Pharmaceuticals
RCKT
$336M
| $3.56M | ﹤0.01% |
+179,216
| New | +$3.62M |
|
2914
Alpha Teknova
TKNO
$268M
| $3.55M | ﹤0.01% |
1,330,741
+81,654
| +7% | +$219K |
|
|
ABST
2915
DELISTED
Absolute Software Corp
ABST
| $3.54M | ﹤0.01% |
309,273
+279,960
| +955% | +$2.8M |
|
2916
Stratasys
SSYS
$688M
| $3.54M | ﹤0.01% |
199,287
-181,631
| -48% | -$2.84M |
|
2917
Ranpak Holdings
PACK
$414M
| $3.53M | ﹤0.01% |
+782,022
| New | +$3.11M |
|
2918
Sana Biotechnology
SANA
$877M
| $3.53M | ﹤0.01% |
592,345
+258,458
| +77% | +$1.49M |
|
2919
Artivion
AORT
$1.31B
| $3.53M | ﹤0.01% |
205,336
-165,391
| -45% | -$2.44M |
|
|
USX
2920
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $3.52M | ﹤0.01% |
574,003
+83,965
| +17% | +$508K |
|
2921
Lennox International
LII
$14.5B
| $3.52M | ﹤0.01% |
10,801
-19,410
| -64% | -$5.49M |
|
|
ELEV
2922
DELISTED
Elevation Oncology
ELEV
| $3.52M | ﹤0.01% |
+2,316,426
| New | +$6.11M |
|
|
MNTN
2923
DELISTED
Everest Consolidator Acquisition Corporation
MNTN
| $3.51M | ﹤0.01% |
330,000
| – | – |
|
2924
CALL
Quest Diagnostics
DGX
$25.8B
| $3.51M | ﹤0.01% |
+25,000
| New | +$3.45M |
|
2925
Vanguard High Dividend Yield ETF
VYM
$80.4B
| $3.51M | ﹤0.01% |
+33,057
| New | +$3.47M |
|
Similar funds
Millennium Management's Q2 2023 Portfolio in Review
As of Q2 2023, Millennium Management held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Millennium Management deployed $14B of net new capital in Q2 2023, opening 869 new positions and adding to 2,214 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, up from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.
- Millennium Management's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Millennium Management added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Millennium Management's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Millennium Management fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Millennium Management's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Millennium Management opened 869 new positions and closed 1,192 in Q2 2023.
- Millennium Management's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.